
As the use of medical aesthetics treatments expands, the field is moving away from excessive volume correction toward a focus on natural balance and improved skin quality.
As the proportion of surgical procedures decreases, minimally invasive procedures are expanding, and a strategy focused on maintaining long-term safety and efficacy is becoming more critical.
DailyPharm met with Dr.
Jonathan Kadouch, a dermatologist in the Netherlands, to discuss trends in global medical aesthetics and strategies for safety management in injectable procedures.
"From overcorrection to balance...natural aesthetics is trending" Dr.
Kadouch explained that the most significant recent change in the field of medical aesthetics is the 'transition from overcorrection to natural harmony.'

Jonathan Kadouch (dermatologist in the Netherlands)"Over the past 20 years, surgical procedures have decreased, and minimally invasive injectable procedures have become the mainstream," he said.
"The focus is shifting from simply adding volume to restoring balance, considering the face's structure and tissue changes." Notably, strategies to enhance the skin's inherent quality and its regeneration process are currently gaining attention.
Dr.
Kadouch said, "Regenerative aesthetics is not just about creating volume, but about creating an environment where tissues can heal themselves," and added, "As interest in regenerative medicine, such as quality improvement, is growing, the medical aesthetics trend is evolving toward prioritizing procedure safety." Dr.
Kadouch also emphasized, "In the past, artificially correcting many areas of the face was popular, but now, both patients and medical professionals prioritize natural and long-term sustainable results." "HA and CaHA differ in mechanism and complication management" The major injectable agents are Hyaluronic Acid (HA) fillers and Calcium Hydroxylapatite (CaHA).
Although they appear similar, the two agents differ in their mechanisms of action and approaches to managing complications.
First, HA fillers are characterized by their degradability with hyaluronidase.
This allows for immediate management should side effects occur or if aesthetic adjustments are needed during the procedure.
In contrast, CaHA is a microparticle that induces collagen and elastin production as it gradually degrades in the body.
Dr.
Kadouch distinguished them, explaining, "HA is a natural component of the human body found in joints, eyes, and skin, and has established itself in the medical aesthetics market for improving volume and wrinkles." He added, "CaHA is a biostimulator that promotes tissue regeneration, where anatomical understanding and the precision of the injection layer determine the treatment outcome." Given the high interest in minimally invasive procedures and safety, the approach to managing complications differs between HA and CaHA.
Dr.
Kadouch explained, "The biggest advantage of HA filler is its reversibility, meaning most issues can be managed by dissolving the filler using hyaluronidase." He noted, "CaHA lacks a dissolving enzyme, requiring an algorithm-based approach to reduce particle concentration or induce tissue diffusion." Dr.
Kadouch also mentioned, "The lack of a specific dissolving agent can be a burden for practitioners with limited clinical experience with CaHA.
However, as CaHA is increasingly used for regenerative purposes rather than volume correction, the risks of complications and side effects have significantly reduced compared to the past." "Evidence-based product selection and patient expectation management are key" Notably, Dr.
Kadouch emphasized that while complications and adverse reactions from filler procedures are often multifactorial, selecting products based on scientific evidence is crucial for ensuring procedure safety.
"The more clinical papers and research results a product has accumulated to prove its safety and efficacy, the higher the confidence a practitioner can have in selecting that product," Dr.
Kadouch said.
"Therefore, rationale decision-making based on objective data and literature is the starting point for safe procedures." Dr.
Kadouch said, "Some biostimulator agents have long-proven safety and efficacy," and added, "In contrast, some rapidly expanding new products lack sufficient data accumulation, necessitating a cautious approach." He also explained that with the increase in patients requesting specific procedures seen on social media, the consultation process is important for managing patient expectations.
Dr.
Kadouch stated, "As information dissemination through social media accelerates, the speed at which specific procedures or products become trends has also become very fast.
Combined with new products and marketing, physicians in the medical aesthetics field face greater challenges than before." However, Dr.
Kadouch believes that medical professionals must uphold their medical convictions and ethical standards while still meeting patient expectations amid this changing trend.
Dr.
Kadouch emphasized, "If medical professionals present scientific evidence and logical reasons, many patients understand and prioritize safety in their decisions," and stressed, "Adequately guiding patients on the limitations of expectations and the criteria for safe product selection is essential not only for medical ethics but also for providing trust-based treatment." Finally, Dr.
Kadouch projected that the future of the medical aesthetics field will center on improving skin quality, long-term maintenance treatment, and combined-procedure strategies.
Dr.
Kadouch said, "Across the industry, invasive procedures are being minimized, and the shift toward minimally invasive or non-invasive procedures is clear and expected to continue," and added, "Combining the advantages of different procedures to improve overall skin quality is expected to become the core trend in the aesthetics field."
댓글 운영방식은
댓글은 실명게재와 익명게재 방식이 있으며, 실명은 이름과 아이디가 노출됩니다. 익명은 필명으로 등록 가능하며, 대댓글은 익명으로 등록 가능합니다.
댓글 노출방식은
댓글 명예자문위원(팜-코니언-필기모양 아이콘)으로 위촉된 데일리팜 회원의 댓글은 ‘게시판형 보기’와 ’펼쳐보기형’ 리스트에서 항상 최상단에 노출됩니다. 새로운 댓글을 올리는 일반회원은 ‘게시판형’과 ‘펼쳐보기형’ 모두 팜코니언 회원이 쓴 댓글의 하단에 실시간 노출됩니다.
댓글의 삭제 기준은
다음의 경우 사전 통보없이 삭제하고 아이디 이용정지 또는 영구 가입제한이 될 수도 있습니다.
저작권·인격권 등 타인의 권리를 침해하는 경우
상용 프로그램의 등록과 게재, 배포를 안내하는 게시물
타인 또는 제3자의 저작권 및 기타 권리를 침해한 내용을 담은 게시물
근거 없는 비방·명예를 훼손하는 게시물
특정 이용자 및 개인에 대한 인신 공격적인 내용의 글 및 직접적인 욕설이 사용된 경우
특정 지역 및 종교간의 감정대립을 조장하는 내용
사실 확인이 안된 소문을 유포 시키는 경우
욕설과 비어, 속어를 담은 내용
정당법 및 공직선거법, 관계 법령에 저촉되는 경우(선관위 요청 시 즉시 삭제)
특정 지역이나 단체를 비하하는 경우
특정인의 명예를 훼손하여 해당인이 삭제를 요청하는 경우
특정인의 개인정보(주민등록번호, 전화, 상세주소 등)를 무단으로 게시하는 경우
타인의 ID 혹은 닉네임을 도용하는 경우
게시판 특성상 제한되는 내용
서비스 주제와 맞지 않는 내용의 글을 게재한 경우
동일 내용의 연속 게재 및 여러 기사에 중복 게재한 경우
부분적으로 변경하여 반복 게재하는 경우도 포함
제목과 관련 없는 내용의 게시물, 제목과 본문이 무관한 경우
돈벌기 및 직·간접 상업적 목적의 내용이 포함된 게시물
게시물 읽기 유도 등을 위해 내용과 무관한 제목을 사용한 경우
수사기관 등의 공식적인 요청이 있는 경우
기타사항
각 서비스의 필요성에 따라 미리 공지한 경우
기타 법률에 저촉되는 정보 게재를 목적으로 할 경우
기타 원만한 운영을 위해 운영자가 필요하다고 판단되는 내용
사실 관계 확인 후 삭제
저작권자로부터 허락받지 않은 내용을 무단 게재, 복제, 배포하는 경우
타인의 초상권을 침해하거나 개인정보를 유출하는 경우
당사에 제공한 이용자의 정보가 허위인 경우 (타인의 ID, 비밀번호 도용 등)
※이상의 내용중 일부 사항에 적용될 경우 이용약관 및 관련 법률에 의해 제재를 받으실 수도 있으며, 민·형사상 처벌을 받을 수도 있습니다.
※위에 명시되지 않은 내용이더라도 불법적인 내용으로 판단되거나 데일리팜 서비스에 바람직하지 않다고 판단되는 경우는 선 조치 이후 본 관리 기준을 수정 공시하겠습니다.
※기타 문의 사항은 데일리팜 운영자에게 연락주십시오. 메일 주소는 dailypharm@dailypharm.com입니다.